Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015674 (
chronic fatigue syndrome
)
2,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gene expression of key enzymes in 2 antiviral pathways (
ribonuclease
latent [RNase L] and RNA-regulated protein kinase [PKR]) was compared in 22 patients with
chronic fatigue syndrome
(
CFS
), 10 patients with acute gastroenteritis, and 21 healthy volunteers. Pathway activation in the group of patients with infections differed significantly from that of the other 2 groups, in whom there was no evidence of upregulation. Therefore, assay of activation is unlikely to provide the basis for a diagnostic test for
CFS
.
...
PMID:Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. 1198 43
Cancer and
chronic fatigue syndrome
(
CFS
) are both characterised by fatigue and severe disability. Besides fatigue, certain aspects of immune dysfunctions appear to be present in both illnesses. In this regard, a literature review of overlapping immune dysfunctions in
CFS
and cancer is provided. Special emphasis is given to the relationship between immune dysfunctions and fatigue. Abnormalities in
ribonuclease
(
RNase
) L and hyperactivation of nuclear factor kappa beta (NF-kappaB) are present in
CFS
and in prostate cancer. Malfunctioning of natural killer (NK) cells has long been recognised as an important factor in the development and reoccurrence of cancer, and has been documented repeatedly in
CFS
patients. The dysregulation of the RNase L pathway, hyperactive NF-kappaB leading to disturbed apoptotic mechanisms and oxidative stress or excessive nitric oxide, and low NK activity may play a role in the two diseases and in the physiopathology of the common symptom fatigue. However, in cancer the relation between the immune dysfunctions and fatigue has been poorly studied. Immunological abnormalities to such as a dysregulated RNase L pathway, hyperactive NF-kappaB, increased oxidative stress and reduced NK cytotoxicity, among others, are present in both diseases. These anomalies may be part of the physiopathology of some of the common complaints, such as fatigue. Further studies to confirm the hypotheses given here are warranted.
...
PMID:Immunological similarities between cancer and chronic fatigue syndrome: the common link to fatigue? 2003 25